Analyst Research

Report Title Price
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: GlobalData
Provider: Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Quest Diagnostics Inc raises FY 2014 guidance

Monday, 10 Mar 2014 07:00am EDT 

Quest Diagnostics Inc:Expects FY 2014 revenues to increase 2-4 pct over FY 2013, versus the prior guidance of flat to down 2 pct.Expects FY 2014 adjusted earnings per diluted share to be between $3.95-$4.15, versus the prior guidance of between $3.90 and $4.10.Reported revenue of $7.146 billion in FY 2013.FY 2014 revenue of $7.214 billion and EPS of $4.03 - Thomson Reuters I/B/E/S.